StockData
MiMedx Group, Inc. logo

MiMedx Group, Inc. (MDXG) stock

MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3034% below fair value
$3.18+0.00 (0.00%)

Close on Nov 18, 2026Market cap $464.04MP/E –Yield –

MiMedx revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

MiMedx's revenue for the twelve months ending Sep 30, 2026 was $303.73M, down 22.8% year over year. For fiscal 2025 it was $418.63M, up 20.0% from the year before. Over ten years it grew 8.4% a year on average. The highest annual figure on record is $418.63M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$418.63M+20.0%
FY2024Dec 31, 2024$348.88M+8.5%
FY2023Dec 31, 2023$321.48M+20.0%
FY2022Dec 31, 2022$267.84M+10.7%
FY2021Dec 31, 2021$242.02M-2.5%
FY2020Dec 31, 2020$248.23M-17.0%
FY2019Dec 31, 2019$299.26M-16.7%
FY2018Dec 31, 2018$359.11M+11.8%
FY2017Dec 31, 2017$321.14M+44.8%
FY2016Dec 31, 2016$221.71M+18.4%
FY2015Dec 31, 2015$187.30M+58.4%
FY2014Dec 31, 2014$118.22M+99.8%
FY2013Dec 31, 2013$59.18M+118.8%
FY2012Dec 31, 2012$27.05M+248.6%
FY2011Dec 31, 2011$7.76M+883.7%
FY2010Dec 31, 2010$788.87K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$62.28M-45.2%
Q2 FY2026Jun 30, 2026$64.36M-34.7%
Q1 FY2026Mar 31, 2026$58.99M-33.1%
Q4 FY2025Dec 31, 2025$118.10M+27.1%
Q3 FY2025Sep 30, 2025$113.73M+35.3%
Q2 FY2025Jun 30, 2025$98.61M+13.1%
Q1 FY2025Mar 31, 2025$88.21M+4.1%
Q4 FY2024Dec 31, 2024$92.91M+7.0%
Q3 FY2024Sep 30, 2024$84.06M+2.9%
Q2 FY2024Jun 30, 2024$87.21M+7.3%
Q1 FY2024Mar 31, 2024$84.71M+18.2%
Q4 FY2023Dec 31, 2023$86.83M+16.7%
Q3 FY2023Sep 30, 2023$81.71M+20.7%
Q2 FY2023Jun 30, 2023$81.26M+21.5%
Q1 FY2023Mar 31, 2023$71.68M+21.7%
Q4 FY2022Dec 31, 2022$74.38M+46.4%
Q3 FY2022Sep 30, 2022$67.69M+7.3%
Q2 FY2022Jun 30, 2022$66.88M-1.9%
Q1 FY2022Mar 31, 2022$58.89M-1.8%
Q4 FY2021Dec 31, 2021$50.81M-25.9%
Q3 FY2021Sep 30, 2021$63.07M-1.9%
Q2 FY2021Jun 30, 2021$68.17M+27.1%
Q1 FY2021Mar 31, 2021$59.97M-2.9%
Q4 FY2020Dec 31, 2020$68.55M-10.3%
Q3 FY2020Sep 30, 2020$64.30M-27.6%
Q2 FY2020Jun 30, 2020$53.65M-20.4%
Q1 FY2020Mar 31, 2020$61.74M-7.2%
Q4 FY2019Dec 31, 2019$76.40M-17.5%
Q3 FY2019Sep 30, 2019$88.86M+2.2%
Q2 FY2019Jun 30, 2019$67.44M-29.3%
Q1 FY2019Mar 31, 2019$66.56M-20.9%
Q4 FY2018Dec 31, 2018$92.59M+5.4%
Q3 FY2018Sep 30, 2018$86.96M+3.5%
Q2 FY2018Jun 30, 2018$95.42M+18.5%
Q1 FY2018Mar 31, 2018$84.15M+22.3%
Q4 FY2017Dec 31, 2017$87.86M+25.7%
Q3 FY2017Sep 30, 2017$84.00M–
Q2 FY2017Jun 30, 2017$80.49M–
Q1 FY2017Mar 31, 2017$68.80M–
Q4 FY2016Dec 31, 2016$69.88M–

More MiMedx figures

See a number that looks wrong?